Needlefree port protection

0

marketwatch.com reported that the Ivera Medical Corporation today announced an exclusive license agreement with BD, for the worldwide rights to selected BD-issued and pending patents for an intravenous port protector designed to reduce the potential for healthcare-acquired bloodstream infections.

“The licensing agreement between BD and Ivera broadens our existing patent applications and removes potential patent issues so we can move forward with the worldwide marketing and sales of the Curos Port Protector,” Jack Saladow, Ivera Vice President of Marketing and Sales said.

Click here for the full story.
marketwatch.com reported that the Ivera Medical Corporation today announced an exclusive license agreement with BD, for the worldwide rights to selected BD-issued and pending patents for an intravenous port protector designed to reduce the potential for healthcare-acquired bloodstream infections.

“The licensing agreement between BD and Ivera broadens our existing patent applications and removes potential patent issues so we can move forward with the worldwide marketing and sales of the Curos Port Protector,” Jack Saladow, Ivera Vice President of Marketing and Sales said.

Click here for the full story.

Share.

Comments are closed.

Free Email Updates
Join 5.5K IVTEAM members. Subscribe now and be the first to receive all the latest free updates from IVTEAM!
100% Privacy. We don't spam.